Non-small Cell Lung Cancer (NSCLC), Stage IV
Also known as: Non-small-cell Lung Cancer (NSCLC) Stage IV / Stage 4 Non-small cell lung cancer / Lung Cancer Non-small Cell Stage IV / Non-small Cell Lung Cancer (NSCLC) Stage IV / Non-small cell lung cancer stage IV / Non-small cell lung cancer metastatic
Drug | Drug Name | Drug Description |
---|---|---|
DB00441 | Gemcitabine | A nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05928 | Dovitinib | 1 | Terminated | 1 |
DB00530 | Erlotinib | 1 | Terminated | 1 |
DB00135 | Tyrosine | 1 | Terminated | 1 |
DB09330 | Osimertinib | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 3 | Recruiting | 2 |
DB06643 | Denosumab | 3 | Active Not Recruiting | 1 |
DB12349 | Dulanermin | 3 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 3 | Recruiting | 1 |
DB00642 | Pemetrexed | 3 | Recruiting | 1 |
DB00945 | Acetylsalicylic acid | Not Available | Not Yet Recruiting | 1 |
DB09330 | Osimertinib | Not Available | Not Yet Recruiting | 1 |